Tag Archives: Deputy Surgeon General Boris Lushniak

U.S. Surgeon General Regina Benjamin Stepping Down in July

    left to right: Mary Woolley, president and CEO, Research!America; Jack T. Watters, MD, Research!America Board member and VP for External Medical Affairs, Pfizer Inc.; and U.S. Surgeon General Regina Benjamin, MD, at Research!America’s 2012 Advocacy Awards Dinner

left to right: Mary Woolley, president and CEO, Research!America; Jack T. Watters, MD, Research!America Board member and VP for External Medical Affairs, Pfizer Inc.; and U.S. Surgeon General Regina Benjamin, MD, at Research!America’s 2012 Advocacy Awards Dinner

Surgeon General Regina Benjamin, MD, recently announced her resignation as the nation’s top doctor after four years in the post.

Dr. Benjamin, the 18th surgeon general, has been an active advocate for public health with a special interest in disease prevention, smoking cessation and healthy lifestyles.

“She has been a remarkable advocate in promoting the value of prevention as a national health priority. She forged the way as leader of the National Prevention Council, created under the Affordable Care Act, to help transform our nation’s health system from one that focuses on treating disease to one that focuses on prevention and staying well,” said Research!America Board member and American Public Health Association Executive Director Georges Benjamin, MD, in a press release.

Deputy Surgeon General Boris Lushniak, MD, MPH, will serve as acting Surgeon General in July while a permanent replacement is sought.

Advertisements

A Weekly Advocacy Message from Mary Woolley: What’s wrong with this picture?

Dear Research Advocate:

According to our new national public opinion poll on clinical trials and related topics, most Americans are willing to share their personal health data to advance research, and 72% would be willing to participate in a clinical trial if recommended by their doctor. This complements what we know from other polling, i.e. that Americans want research to proceed at a pace of scientific opportunity. Yet we continue to lose ground in the gridlocked political environment, which, by its inaction, is dashing the hopes of patients and families anxious for new therapies and cures. What’s wrong with this picture?

It isn’t as though research hasn’t yielded both societal and economic benefits! United for Medical Research (UMR) and Battelle Technology Partnership Practice have released a report on the economic and transformative impact of the Human Genome Project, timed as we celebrate the 10th anniversary of its completion. This visionary project has resulted in wildly successful public-private partnerships, more than 4.3 million job-years of supported employment, and nearly $1 trillion in total economic impact since 1988.

The goals of the BRAIN Initiative have been compared to those of the Human Genome Project. Breakthroughs are so desperately needed to overcome Alzheimer’s and a plethora of other serious illnesses. In a recent Bloomberg View article, columnist Al Hunt points out the folly of starving research while we are faced with such major health challenges. Continue reading →